Member Info for whimax

Sorry HarryCarter, but that’s all just utter drivel.

For starters, Chariot own the licence, ENOG only Farmed In and became Operator, not owner. If they walk away, they are not entitled to “sell on” their ‘bits’ to third parties (lol, that’s just absolute nonsense 🤣). If they walk, their share reverts back to Chariot, simple as that.

You’ve done nothing but copy and paste someone else’s rubbish on to here since the day you first appeared, and you clearly know nothing, either about Chariot or how the sector works in general.

You’re an absolute clown and my previous statement still holds. You’ve now gone from “it’s common knowledge on the rig) to “I’m only passing on what I’ve heard” and “rumours”.

You better be very careful or you’re going to end up in the middle of something you don’t want be. I have a screenshot of your post from earlier that Admin took down.

Harrycarter, you’re skating on very thin ice here with these spurious accusations against Chariot & ENOG, as is the individual on the other forum who keeps feeding this nonsense.

There is a very good reason your last post on this matter has now been deleted by LSE Admin.

I suggest that unless you back up these accusations with cold, hard evidence or facts, that you do not continue down this path.

From the press release!! 👍🏻😊

“ At the ROK-led MSP Project Deep Dive meeting, participants discussed the challenges to developing specific MSP projects, including HyProMag’s rare earth elements recycling project in the UK, Germany and the US, and the newly added Arafura Rare Earths’ Nolans Project in Australia, and identified means to advance these projects. Additionally, the Korea Institute of Geoscience and Mineral Resources (KIGAM) provided a briefing on its REEs recycling technology and ongoing projects.”

You are literally full to the brim with shyte, Harry.

That’s clearly the last thing you want.

TIziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association

19th November 2024

NEW YORK, November 19, 2024 – Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that its grant application to the ALS Association has been approved for funding. The grant is awarded as part of the Hoffman ALS Clinical Trial Awards Program and is titled “Modulation of ALS neuroinflammation by nasal anti-CD3 monoclonal Antibody”. The Association’s grant will fund a 20-patient clinical trial of two doses of Tiziana’s novel and patented therapeutic candidate, intranasal foralumab, aimed at evaluating the safety and early-stage parameters of disease improvement in Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease.

https://www.tizianalifesciences.com/tiziana-life-sciences-announces-groundbreaking-als-trial-grant-awarded-by-the-als-association/

ReplyRecomme

Iziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association

19th November 2024

NEW YORK, November 19, 2024 – Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that its grant application to the ALS Association has been approved for funding. The grant is awarded as part of the Hoffman ALS Clinical Trial Awards Program and is titled “Modulation of ALS neuroinflammation by nasal anti-CD3 monoclonal Antibody”. The Association’s grant will fund a 20-patient clinical trial of two doses of Tiziana’s novel and patented therapeutic candidate, intranasal foralumab, aimed at evaluating the safety and early-stage parameters of disease improvement in Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease.

https://www.tizianalifesciences.com/tiziana-life-sciences-announces-groundbreaking-als-trial-grant-awarded-by-the-als-association/

Luckily, ours is also already valued at zero 🥴

The only time you post Ffx, is when you’ve actually got nothing to say 😉

😂

So why are you wasting your time posting here? 😂

Why do you care?

You really are a weirdo FFX. I’ve no idea what would possess someone (who continually tries to have us believe they are a holder) to make idiotic comments such as those, unprompted.

You really are a very strange person indeed.

Not that you’ll care either way HarryCarter, obviously, as you’ve already stated you’ve sold. Yet here you are? 🤷🏻‍♂️

What a sad life you must lead, if posting on bb’s of companies you’re not invested in is what floats your boat.

I think the less said about HarryCarter the better.

Absolute weapon!!

Jeez, change the record ffx, or better still, just sell and fof. 🤦‍♂️

Good for you Chab 👏

This is THEE perfect opportunity for all those who have been incessantly whinging and moaning for the past 2+ years, to get out.

If you don’t take it, you will have absolutely zero credibility, and thoroughly deserve to lose your money, if this doesn’t pan out as we hope.

To everyone else, good luck with your investment.

* not worth responding lol.

It’s cos everyone has either got you filtered kingbilly, or your reputation for talking absolute drivel goes before you and they know it’s worth responding.

Luckily you’ve still got Smyth11 to ‘recommend’ your posts, or you’d be call LSE asking them to check your account is still active 😂